Botanical species · safety record

Doryphora sassafras

The EFSA Compendium of Botanicals holds 10 constituent measurements for Doryphora sassafras. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Doryphora sassafras Endl.

10Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Isocorydine	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Isoquinoline alkaloids	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Unspecified	No resolvable identifier
Alkaloids	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Camphor	Aerial part of plants	Essential oil	≥ 15 Percent	Unspecified	No resolvable identifier
Camphor	Aerial part of plants	Essential oil	≤ 19 Percent	Unspecified	No resolvable identifier
Methyleugenol	Aerial part of plants	Essential oil	≤ 47 Percent	Unspecified	No resolvable identifier
Methyleugenol	Aerial part of plants	Essential oil	≥ 27 Percent	Unspecified	No resolvable identifier
Safrole	Aerial part of plants	Essential oil	≤ 30 Percent	Unspecified	No resolvable identifier
Safrole	Aerial part of plants	Essential oil	≥ 15 Percent	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Brophy, Joseph J., Goldsack, Robert J., House, Alan P.N., Lassak, Erich V. Essential oils of the genus Doryphora. Journal of Essential Oil Research, 1993, vol. 5, no. 6, p. 581-586.
Carroll, AR., Davis, RA., Forster, PI., Guymer, GP., Quinn, RJ. A benzylisoquinoline alkaloid from Doryphora sassafras. JOURNAL OF NATURAL PRODUCTS, 2001, vol. 64, no. 12, p. 1572-1573. DOI
Buchanan, Malcolm S., Davis, Rohan A., Duffy, Sandra., Avery, Vicky M., Quinn, Ronald J. Antimalarial Benzylisoquinoline Alkaloid from the Rainforest Tree Doryphora sassafras. JOURNAL OF NATURAL PRODUCTS, 2009, vol. 72, no. 8, p. 1541-1543. DOI
Gharbo, Samir A., Beal, Jack L., Schlessinger, Richard H., Cava, Michael P., Svoboda, Gordon H. Phytochemical study of Doryphora sassafras. I. Isolation of eight crystalline alkaloids from the leaves. Lloydia, 1965, p. 237-244.
Chen, C. Rolland., Beal, Jack L., Doskotch, Raymond W., Mitscher, Lester A., Svoboda, Gordon H. Phytochemical study of Doryphora sassafras. II. Isolation of eleven crystalline alkaloids from the bark. Lloydia, 1974, p. 493-500.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature